精神病患者灰质体积与纹状体多巴胺功能的关系:多模态18F-DOPA PET与基于体素的形态学研究
结果发现治疗应答者前额叶灰质体积与纹状体多巴胺合成能力呈负相关,而治疗非应答者无此关系,且在独立样本中重复验证了右侧前额叶的发现。
要点
- 治疗应答的精神病患者前额叶灰质体积与纹状体多巴胺合成能力呈负相关。
- 治疗非应答者中未观察到前额叶灰质体积与纹状体多巴胺合成能力的关联。
- 该关联在独立样本右侧前额叶皮层得到重复验证,总结效应量为0.82。
核心结论
- 研究结果支持纹状体多巴胺系统失调与前额叶皮层病理相关的长期假说,但仅适用于治疗应答的精神分裂症患者。
- 提示治疗应答与治疗抵抗的精神分裂症可能由不同病理生理机制驱动。
研究设计与样本
- 结构图像采用DARTEL-VBM处理,在SPM12中进行一般线性模型分析,检验前额叶灰质体积与纹状体Kicer的关系。
主要发现
- 治疗应答者前额叶灰质体积与纹状体多巴胺合成能力呈负相关,而治疗非应答者中未见此关联。
- 治疗应答、全纹状体多巴胺合成能力与灰质体积的交互作用在左侧前额叶皮层(pFWE corr. = 0.017)和右侧前额叶皮层(pFWE corr. = 0.042)显著。
- 在独立样本中重复验证了右侧前额叶皮层的发现(pFWE corr. = 0.031),总结效应量为0.82。
临床怎么用
- 对于治疗应答的精神病患者,前额叶灰质体积与纹状体多巴胺合成能力的负相关可能提示多巴胺机制在其病理生理中的核心作用。
- 治疗非应答者缺乏此关联,提示其病理机制可能不同于治疗应答者,临床评估中需考虑治疗反应分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A leading hypothesis for schizophrenia and related psychotic disorders proposes that cortical brain disruption leads to subcortical dopaminergic dysfunction, which underlies psychosis in the majority of patients who respond to treatment. Although supported by preclinical findings that prefrontal cortical lesions lead to striatal dopamine dysregulation, the relationship between prefrontal structural volume and striatal dopamine function has not been tested in people with psychosis. We therefore investigated the in vivo relationship between striatal dopamine synthesis capacity and prefrontal grey matter volume in treatment-responsive patients with psychosis, and compared them to treatment non-responsive patients, where dopaminergic mechanisms are not thought to be central. Forty patients with psychosis across two independent cohorts underwent 18F-DOPA PET scans to measure dopamine synthesis capacity (indexed as the influx rate constant Kicer) and structural 3T MRI. The PET, but not MR, data have been reported previously. Structural images were processed using DARTEL-VBM. GLM analyses were performed in SPM12 to test the relationship between prefrontal grey matter volume and striatal Kicer. Treatment responders showed a negative correlation between prefrontal grey matter and striatal dopamine synthesis capacity, but this was not evident in treatment non-responders. Specifically, we found an interaction between treatment response, whole striatal dopamine synthesis capacity and grey matter volume in left (pFWE corr. = 0.017) and right (pFWE corr. = 0.042) prefrontal cortex. We replicated the finding in right prefrontal cortex in the independent sample (pFWE corr. = 0.031). The summary effect size was 0.82. Our findings are consistent with the long-standing hypothesis of dysregulation of the striatal dopaminergic system being related to prefrontal cortex pathology in schizophrenia, but critically also extend the hypothesis to indicate it can be applied to treatment-responsive schizophrenia only. This suggests that different mechanisms underlie the pathophysiology of treatment-responsive and treatment-resistant schizophrenia.
引用
- D'Ambrosio E, Jauhar S, Kim S, et al. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal 18F-DOPA PET and voxel-based morphometry study. Mol Psychiatry. 2019. PMID: 31690805. doi:10.1038/s41380-019-0570-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。